Related Experiment Video
Updated: Jun 8, 2026

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
Published on: July 28, 2023
Why don't we have more effective treatment for keloids?
Romana Ceović1, Jasna Lipozenčić, Zrinka Bukvić Mokos
1University Hospital Center Zagreb, Department of Dermatology and Venereology, School of Medicine, University of Zagreb, Šalata 4, Zagreb, Croatia. romana.ceovic@zg.htnet.hr
Abstract:
Numerous treatment modalities have been used to treat keloids and hypertrophic scars, but optimal treatment has not yet been established. The failure of achieving better therapeutic results in treating keloids highlights the essential problem that the pathogenetic mechanisms causing keloids remain unclear. Increased understanding at the molecular level will lead to the development of new therapies. Prevention is the first rule in keloid therapy. Conventional and experimental therapeutic approaches are presented in this review but further investigation is needed in relation to safety, adverse effects, and therapeutic efficacy. Because of the high recurrence rate of keloid scars, a follow-up period of at least 1 year is required to enable the start of treatment of recurrences as expediently as possible and to evaluate long-term success.
Insights
Optimal keloid and hypertrophic scar treatment remains elusive due to unclear pathogenetic mechanisms. Further research into molecular causes and therapeutic efficacy is crucial for developing effective treatments and preventing recurrence.
Area of Science:
- Dermatology
- Wound Healing
- Scar Research
Background:
- Keloids and hypertrophic scars present significant therapeutic challenges.
- Current treatment modalities lack established optimal protocols.
- The underlying pathogenetic mechanisms of keloid formation are not fully understood.
Purpose of the Study:
- To review current conventional and experimental therapeutic approaches for keloids and hypertrophic scars.
- To highlight the need for a deeper understanding of molecular mechanisms in keloid pathogenesis.
- To emphasize the importance of prevention and long-term follow-up in keloid management.
Main Methods:
- Review of existing literature on keloid and hypertrophic scar treatments.
- Discussion of conventional therapeutic strategies.
- Exploration of experimental approaches and their limitations.
Main Results:
- No single optimal treatment has been established for keloids and hypertrophic scars.
- Understanding molecular mechanisms is key to developing novel therapies.
- High recurrence rates necessitate prolonged follow-up for evaluating treatment success.
Conclusions:
- Further investigation into safety, adverse effects, and efficacy of treatments is required.
- Prevention remains a primary strategy in keloid therapy.
- A minimum one-year follow-up is essential for assessing long-term outcomes and managing recurrences.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Healing II: Complications
Acne Infection
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
